Global Cuffless Blood Pressure Monitor Market Size Study & Forecast, by Type (Wrist-based, Finger-based monitors, Armband-based monitors), By End-use (Home Healthcare Settings, Hospitals, Diagnostics Centers, Other healthcare facilities), and Regional Ana

Global Cuffless Blood Pressure Monitor Market Size Study & Forecast, by Type (Wrist-based, Finger-based monitors, Armband-based monitors), By End-use (Home Healthcare Settings, Hospitals, Diagnostics Centers, Other healthcare facilities), and Regional Analysis, 2023-2030

Global Cuffless Blood Pressure Monitor Market is valued at approximately USD 585.5 million in 2022 and is anticipated to grow with a healthy growth rate of more than 10.9% over the forecast period 2023-2030. Cuffless blood pressure monitor is a device that measures blood pressure without using an inflatable cuff typically found in traditional blood pressure monitors. Cuffless blood pressure monitors employ various technologies, such as photoplethysmography (PPG) and pulse wave analysis (PWA), to measure blood pressure. These devices often consist of sensors that detect changes in blood volume and blood flow within the body, typically in the finger, wrist, or other peripheral regions. The sensors capture the pulse waveforms and analyze them to determine the systolic and diastolic blood pressure values. The Cuffless Blood Pressure Monitor Market is expanding because of factors such as the growing geriatric population, surging demand for home-based healthcare monitoring, rising awareness about the importance of blood pressure monitoring, and increasing healthcare expenditure.

In addition, the rising prevalence of hypertension or high blood pressure, and other cardiovascular diseases is acting as a catalyzing factor for market growth across the globe. Hypertension affects a significant portion of the global population. According to the World Health Organization, it is estimated that nearly 1.28 billion persons worldwide between the ages of 30 and 79 are suffering from hypertension, along with approximately 46% of individuals with hypertension unaware that they have the ailment and two-thirds of the patients living in low- and middle-income countries. Also, the World Health Organization (WHO) reported that in 2021, cardiovascular diseases (CVD) are the number leading cause of death globally with approximately 17.9 million deaths annually. Accordingly, the demand for convenient and accurate blood pressure monitoring devices like cuffless monitors increases because of the rising awareness about risks associated with hypertension. Thus, these aforementioned factors are propelling the growth of the Cuffless Blood Pressure Monitor Market during the estimated period. Moreover, the growing focus on preventive healthcare, as well as the increasing investment in technological development is presenting various lucrative opportunities over the forecasting years. However, the high cost of cuffless blood pressure monitors and accuracy concerns about cuffless blood pressure monitors are hampering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cuffless Blood Pressure Monitor Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the high incidences of hypertension, increasing technological advancements in cuffless blood pressure monitoring technology, along with rising inclination towards wearable health technology. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The rising investment in healthcare infrastructure, increasing government initiatives to promote home-based healthcare monitoring and growing geriatric population are significantly propelling the market demand across the region.

Major market players included in this report are:
Omron Corporation
CardiacSense, Inc.
Valencell, Inc.
SOMNOmedics GmbH
Biospectal Ltd.
Fourth Frontier Technologies LLC
A&D Medical Co., Ltd.
Biobeat Technologies Ltd.
Healthstats International Pte. Ltd.
Huawei Device Co., Ltd.

Recent Developments in the Market:
 In July 2022, Huawei unveiled the introduction of the Watch D, the company’s first wrist-type device that is specially designed for monitoring ECG and blood pressure.
 In January 2023, Valencell showcased the company’s Cuffless Blood Pressure Monitoring device for over-the-counter use. This device enables users to precisely measure their blood pressure from their fingers without a cuff or calibration.


Global Cuffless Blood Pressure Monitor Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Type, End-use, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Wrist-based
Finger-based monitors
Armband-based monitors

By End-use:
Home Healthcare Settings
Hospitals
Diagnostics Center
Other healthcare facilities

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa




Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Companies Mentioned
Omron Corporation
CardiacSense, Inc.
Valencell, Inc.
SOMNOmedics GmbH
Biospectal Ltd.
Fourth Frontier Technologies LLC
A&D Medical Co., Ltd.
Biobeat Technologies Ltd.
Healthstats International Pte. Ltd.
Huawei Device Co., Ltd.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.